Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect Comparison Methodology

BACKGROUND: No head-to-head clinical trials have been published comparing guanfacine extended release (GXR) and atomoxetine (ATX): two nonstimulants approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). However, other study designs or methods could be used to indirectly comp...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Sikirica, Vanja, Findling, Robert L., Signorovitch, James, Erder, M. Haim, Dammerman, Ryan, Hodgkins, Paul, Lu, Mei, Xie, Jipan, Wu, Eric Q.
Format: Artigo
Język:Inglês
Wydane: Springer International Publishing 2013
Hasła przedmiotowe:
Original Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3824845/
https://ncbi.nlm.nih.gov/pubmed/23975660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-013-0102-x
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy